Skip to main content
. 2009 Mar 17;100(7):1026–1031. doi: 10.1038/sj.bjc.6604895

Table 1. Patient demographic characteristics by diagnosis.

Characteristic ALL AML
Age in years, median (range) 5.2 (0.0, 15.1) 5.5 (0.2, 15.7)
Male, N (%) 263 (56) 40 (51)
Initial WBC (109l−1) median (IQR) 11.5 (4.5, 36.3) 15.8 (6.7, 56.6)
Initial haemoglobin (g l−1), median (IQR) 69 (51, 90) 77 (50, 97)
     
Immunophenotype, no (%)
 B lineage 421 (92)  
 T lineage 35 (8)  
     
FAB classification, N (%)
 M0   7 (9)
 M1   18 (24)
 M2   26 (34)
 M4   8 (11)
 M5   6 (8)
 M6   2 (3)
 M7   7 (9)
     
Risk group, N (%)
 Higher risk 194 (44)  
 Standard riska 250 (56)  
     
Parental education, N (%)
 Illiterate 17 (4) 3 (4)
 Primary 290 (63) 51 (67)
 Secondary 107 (23) 18 (24)
 Advanced 41 (9) 3 (4)
 Unknown 4 (1) 1 (1)
     
Hours to travel to clinic, median (IQR) 2.0 (1.0, 3.0) 2.0 (1.0, 3.0)
Monthly household income (dollars), median (IQR) 150 (100, 250) 150 (57, 228)
Body mass index percentile, median (IQR) 43.2 (11.1, 81.3) 41.2 (10.7, 77.8)
Triceps skin-fold thickness percentile, median (IQR) 17.5 (2.5, 62.5) 37.5 (17.5, 62.5)
Mid-upper arm circumference percentile, median (IQR) 17.5 (2.5, 37.5) 17.5 (2.5, 37.5)

Abbreviations: ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia; FAB=French-American-British; IQR=interquartile range; N, number; WBC, white blood cell count; .

a

Standard risk was defined as DNA index ⩾1.16, WBC <50 × 109/l, age >12 months and <10 years, without any of the following: (1) T-cell lineage, (2) CNS leukaemia at diagnosis, (3) testicular leukaemia or (4) bone marrow M3 on day 15 or M2-M3 on day 36.